At the time this study was conducted, Drs. Sliman, Charenkavanich, and Rousculp were employees of MedImmune, LLC, Gaithersburg, MD 20878, USA.
Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*
Article first published online: 14 OCT 2012
© 2012 John Wiley & Sons Ltd
Influenza and Other Respiratory Viruses
Volume 7, Issue 6, pages 1142–1150, November 2013
How to Cite
Sheldon, E. A., Jeanfreau, R., Sliman, J. A., Charenkavanich, S., Rousculp, M. D., Dubovsky, F. and Mallory, R. M. (2013), Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study. Influenza and Other Respiratory Viruses, 7: 1142–1150. doi: 10.1111/irv.12027
Previous presentation: Data from this study were presented at the 48th Annual Meeting of the Infectious Diseases Society of America, October 21–24, 2010, Vancouver, British Columbia, Canada (Abstract No. 3671).
Trial registration: Clinicaltrials.gov identifier NCT00952705.
- Issue published online: 5 NOV 2013
- Article first published online: 14 OCT 2012
- Accepted 08 September 2012. Published Online 14 October 2012.
- MedImmune, LLC
Figure S1. CONSORT diagram; subjectdisposition.
Figure S2. Geometric mean titer by strain, day0.
Table S1. Postvaccination strain-specific HAIantibody titer ≥32 by baseline serostatus.
Data S1. Study investigators.
|irv12027_sm_FigS1.jpg||153K||Supporting info item|
|irv12027_sm_FigS2.jpg||154K||Supporting info item|
|irv12027_sm_OnlineContent.doc||35K||Supporting info item|
|irv12027_sm_TableS1.doc||58K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.